ACS

Featured Article

The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction

The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction

A higher prevalence of traditional cardiovascular risk factors may be partially responsible for the increased incidence of cardiovascular disease in people living with HIV.

Latest Features

The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction

The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction

A higher prevalence of traditional cardiovascular risk factors may be partially responsible for the increased incidence of cardiovascular disease in people living with HIV.

Benefits of Inpatient Smoking Cessation Therapy Post-Myocardial Infarction

Benefits of Inpatient Smoking Cessation Therapy Post-Myocardial Infarction

Hospitals may be missing opportunities to start tobacco use treatment immediately after myocardial infarction.

Cardiac Rehabilitation: Changes, Challenges, and Clinician Perspectives

Cardiac Rehabilitation: Changes, Challenges, and Clinician Perspectives

An overview of cardiac rehabilitation use plus interviews with Monica Mukherjee, MD, MPH, FACC, FASE and with Jonathan Ledyard, MS, RCEP.

Assessing Chest Pain in ER With Short-term Risk Stratification Tool

Assessing Chest Pain in ER With Short-term Risk Stratification Tool

The HEART Score is a safe risk-stratification tool for chest pain, but it does not seem to do much for reducing hospital utilization and admissions.

Oxygen Therapy for Acute MI: Best Practice or Harmful Treatment?

Oxygen Therapy for Acute MI: Best Practice or Harmful Treatment?

Evidence is lacking to support oxygen therapy for acute myocardial infarction.

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

Among patients with heterozygous familial hypercholesterolemia, alirocumab was associated with a 75% reduction in lipoprotein apheresis compared with placebo.

Bioresorbable Stents Promising But Metal Stents Still Have Role in Coronary Intervention

Bioresorbable Stents Promising But Metal Stents Still Have Role in Coronary Intervention

Experts say bioresorbable stents are "a few generations away" from being standard of care in interventional cardiology.

Deferred Stenting or Ischemic Postconditioning in STEMI Patients Did Not Reduce Adverse Events

Deferred Stenting or Ischemic Postconditioning in STEMI Patients Did Not Reduce Adverse Events

A composite end point of death, heart failure, new myocardial infarction, and revascularization was similar between the deferred stenting group and the conventional treatment group.

Room for Improvement: Pharmacologic Management of Acute Coronary Syndromes

Room for Improvement: Pharmacologic Management of Acute Coronary Syndromes

Poor adherence to dual antiplatelet therapy plays a significant role in outcomes for patients with acute coronary syndromes.

Risk of Cardiovascular Disease Questioned in Testosterone Therapy Use

Risk of Cardiovascular Disease Questioned in Testosterone Therapy Use

The American Association of Clinical Endocrinologists site lack of evidence of cardiovascular disease risk in testosterone therapy use.

Latest News

Happy Holidays? Christmas, Midsummer Holidays Linked to Increased MI Risk

Happy Holidays? Christmas, Midsummer Holidays Linked to Increased MI Risk

Researchers examined the relationship between Christmas, New Year's, sporting events, and myocardial infarction.

Ezetimibe Plus Statins Modestly Reduce Cardiovascular Disease Event Risk

Ezetimibe Plus Statins Modestly Reduce Cardiovascular Disease Event Risk

Ezetimibe combined with statin therapy showed modest or moderate benefits in reducing major CVD event risk.

Frailty Associated With Increased Major Bleeding Risk Post-Catheterization for AMI

Frailty Associated With Increased Major Bleeding Risk Post-Catheterization for AMI

Frailty is associated with a higher risk for major bleeding if catheterization is performed for acute myocardial infarction.

First-in-Human Telerobotic Percutaneous Coronary Intervention Successful

First-in-Human Telerobotic Percutaneous Coronary Intervention Successful

The first telerobotic percutaneous coronary intervention was conducted using CorPath telerobotic technology.

Which Biomarkers Provide Prognostic Information on Mortality in Acute Coronary Syndrome?

Which Biomarkers Provide Prognostic Information on Mortality in Acute Coronary Syndrome?

N-terminal pro-B-type natriuretic peptide and growth differentiation factor-15 provide prognostic information in patients with ACS.

Manual Chest Compressions Superior to Mechanical Alternative for Cardiac Arrest

Manual Chest Compressions Superior to Mechanical Alternative for Cardiac Arrest

Mechanical chest compression devices are not superior to conventional, high-quality manual chest compressions.

Incidence of Myocardial Infarction Found to Increase With Cold Weather

Incidence of Myocardial Infarction Found to Increase With Cold Weather

The influence of weather on the incidence of myocardial infarction was examined.

Race-Based Characteristics May Mediate Differences in Acute Myocardial Infarction Outcomes

Race-Based Characteristics May Mediate Differences in Acute Myocardial Infarction Outcomes

Substantial differences were found between black and white participants in demographic, socioeconomic, psychosocial, clinical, disease severity, and health status characteristics.

CABG Superior to PCI-DES for Reducing All-Cause Mortality in Multivessel Disease With Diabetes

CABG Superior to PCI-DES for Reducing All-Cause Mortality in Multivessel Disease With Diabetes

Coronary artery bypass grafting may be a superior revascularization strategy in patients with diabetes and multivessel disease.

Very Low High-Sensitivity Cardiac Troponin Levels May Exclude Inducible Myocardial Ischemia

Very Low High-Sensitivity Cardiac Troponin Levels May Exclude Inducible Myocardial Ischemia

Low hs-cTnI levels may identify patients with CAD who have a low medium-term risk for adverse cardiovascular events.